Peru launches contingency plan as COVID-19 cases rise – MercoPress


Peru launches contingency plan as COVID-19 cases rise

Thursday, November 10, 2022 – 19:26 UTC

Vaccination campaign boosted as part of measures to get Peru through fifth wave

Peruvian health authorities announced an emergency plan on Wednesday amid rising COVID-19 cases in the regions of Lima, Arequipa (south) and Loreto (north).

Given this situation, local experts recommended continuing biosecurity measures such as vaccination, use of masks in high-risk areas, hand washing and social distancing.

“If we want to keep this pandemic under control, we must maintain biosecurity measures, and the main weapon against COVID-19 is vaccination. We have no excuse not to apply these preventive measures,” explained EsSalud epidemiologist Edwin Neciosup.

The South American country’s EsSalud social security agency has reinforced some strategies such as home vaccination, through health brigades that travel to different parts of Lima and other places to inject both the population insured and uninsured. Health personnel have also been deployed to specific locations so that people can complete their immunization schedule, it has been reported.

The increase in the number of cases follows the lifting of the state of emergency, which abolished the compulsory wearing of masks indoors and on public transport. The government nevertheless recommended continuing to be vaccinated to avoid the severe phase of this disease.

The Peruvian Ministry of Health (Minsa) applied 85,309,442 doses of COVID-19 vaccine (26.83 million first doses, 25.75 million second doses, 20.91 million third doses and 5.54 million fourth doses).

The World Health Organization (WHO) said in its weekly report on Wednesday that “vaccination against COVID-19 for people over 60 has been prioritized because they are one of the groups most at risk of serious illness, hospitalization and death in the event of infection with COVID”. -19 virus.

The WHO also admitted that “although we have seen reduced performance of vaccines against newer variants, studies show that COVID-19 vaccines hold up well over time against severe illness, hospitalization and death. if they are infected with the virus that causes COVID-19.”

Meanwhile, Peru’s Minsa also reported 3,299 cases of monkeypox on Wednesday. So far, 3,086 patients have been discharged, while 213 remain under observation. Most cases (2,523) have been detected in Lima, but the disease is thought to be present in at least 20 regions of the country.

The country began on October 7 to vaccinate people against the human immunodeficiency virus (HIV). The campaign aims to vaccinate some 14,000 eligible patients with their two doses 28 days apart.

The ministry also released its manual “Technical Health Standards for the Epidemiological Surveillance of Monkeypox in Peru” this week, which was published in the official newspaper El Peruano. The publication sets out guidelines for the surveillance and epidemiological investigation of monkeypox cases and contacts at the national level by the National Epidemiological Surveillance System (Sinave).


Comments are closed.